Immuno Cure Biotech's ICVAX, a novel therapeutic HIV vaccine, demonstrates a favorable safety profile and promising immunogenicity in a Phase I clinical trial.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.